Eric Pauwels
CIK 1323212 · CHIEF BUSINESS OFFICER · last filed 2026-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.79M
Companies
3
Total Filings
74
Lifetime Open-Market Net
-$12.62M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PTCT | CHIEF BUSINESS OFFICER | 90,977 | $74.52 | $6.78M | -$12.62M | 36 | 2026-06-12 |
| NPS PHARMACEUTICALS INC (NPSP) Delisted | President, NPS Pharma Int'l | 0 | — | — | $0 | 11 | 2015-02-24 |
| ARAY | SVP Chief Marketing Officer | 30,000 | $0.23 | $7.0K | $0 | 1 | 2011-03-01 |
Recent Filings · Page 5 of 8
74 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-05-19 | PTCT | Sell (S) | −8,836 | -$517.1K | EDGAR |
| 2023-05-18 | PTCT | Notice (144) | −788 | -$46.3K | EDGAR |
| 2023-05-17 | PTCT | Notice (144) | −8,048 | -$470.8K | EDGAR |
| 2023-04-20 | PTCT | Sell (S) | −732 | -$38.1K | EDGAR |
| 2023-04-18 | PTCT | Notice (144) | −732 | -$38.1K | EDGAR |
| 2023-02-02 | PTCT | Sell (S) | −375 | -$17.1K | EDGAR |
| 2023-01-26 | PTCT | Sell (S) | −359 | -$17.0K | EDGAR |
| 2023-01-12 | PTCT | Sell (S) | −1,234 | -$53.8K | EDGAR |
| 2023-01-11 | PTCT | Sell (S) | −858 | -$35.7K | EDGAR |
| 2023-01-09 | PTCT | Grant (A) | +18,000 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.